Blog / Archives
Reiterate Caution on Biopharmaceutical Stocks With Major 3% Sector Sell-Off
Raise More Cash- No Change in Rayno Biopharma Portfolio Last month we raised the yellow flag on the biotech sector because of a choppy tape, new highs with weakness in MO (Momentum) plays and the...
Rayno Life Science DX and Tools: Performance YTD 5/28
Rayno Diagnostics and Tools Portfolio Rayno Life Science top picks were up 20 to 53% beating the NASDAQ and S&P. Five new stocks were added in 2013: BG Medicine (BGMD), Genomic Health...
Biotech and Drug Stocks Down as Investors Trim Positions
Biopharmaceutical Stocks Sell-Off with Large Cap Drug Stocks High Flyers du jour-AEGR,INFI 10 Year Treasury Hits 2.13 Yield Caution-no new buys and all portfolio positions on hold Large cap drug...
Rayno Life Science Dx and Tools-Green Day with New Highs-GHDX, NEOG,TMO
Impressive Rally in Diagnostics and Tools Stocks The NASDAQ rally is beginning to fade now up only 17 pts after hitting a high of 3510 at 10 am EDT. However many Life Science Tools and Diagnostics...
Reversal Day-Caution is Back-NASDAQ Down 1% or 35Pts– Update 5/23
Biotechs Bounce Back After Deep Dive Unless you were trading at the open today and covered your shorts you could have been whipsawed in a volatile market that had NASDAQ down to the 3425 level. Many...
When Does the Cost of Cancer Drugs Affect the Market?
Cancer's Bitter Medicine Alex Philippidis in today's Genetic Engineering News provides an excellent review of the treatment costs for CML (chronic myeloid leukemia) which can exceed $100k/year....
Rayno Life Science: Bringing on the Green After a Four Day Rest
Biopharmaceutical Stocks Rally- Many Rayno Picks up 2%+ If the past four days was the long awaited biotechnology correction it was barely noticeable, a mere 3.7% high to low over the past week.Today...
Biotechnology Archives: Human Genome Sciences-Anthrax and Lupus
1999 Biotech Superstar Got Bailed Out By Anthrax antitoxin?! The famous Company that was going to revolutionize drug discovery was saved in 2003 by a government funded bioterror program for Anthrax...
Major Sell-Off in Biopharmaceutical Stocks: Caution and Raise Cash -Update 1
Damage held to the AM-IBB Holds at $180 Two Volatile Stocks Green stocks in our coverage universe: ACHN, BIIB, CBST. Volume on all biotech stocks was above average, so review technicals as this...
Emerging Biomarker Companies Redux: BGMD,RGDX,VRML Positioned for Growth
Biomarker Products for Cardiovascular Disease and Cancer This is the third article on Emerging Biomarker Companies. See 11/15/12 Update The synergies between diagnostics and drugs are growing as...